In a significant move to enhance access to affordable cancer care, the Homi Bhabha Cancer Hospital and Research Centre (HBCH&RC) in Punjab has been empanelled with the Employees' State Insurance Corporation (ESIC) of Haryana for the first time. This collaboration enables ESIC Haryana beneficiaries and staff to receive cashless treatment at both the New Chandigarh and Sangrur campuses of the institute.
Memorandum of Understanding Signed
The Memorandum of Understanding (MoU) was formalized by Dr. Ashish Gulia, Director of HBCH&RC Punjab, and Hari Om Prakash, Regional Director of ESIC Haryana. The signing ceremony was attended by Dr. Abhishek Rai, State Medical Officer of Haryana, along with officials from both organizations. HBCH&RC is a unit of Tata Memorial Centre, an aided institute of the Department of Atomic Energy.
Expanding Empanelment Network
HBCH&RC Punjab is already empanelled with ESIC Punjab, ESIC Chandigarh, ESIC Ludhiana, and ESIC Himachal Pradesh. Between April 1, 2025, and March 31, 2026, approximately 3,000 ESIC cardholders received cashless treatment at HBCH&RC Punjab, reflecting growing trust in the institute's specialized cancer care services.
Services Covered Under ESIC Scheme
Under the ESIC scheme, beneficiaries can access a comprehensive range of healthcare services at the institute, including:
- Outpatient Department (OPD) services
- Inpatient Department (IPD) care
- Diagnostic and laboratory services
- Emergency care
- Day-care services
- Radiotherapy services
Commitment to Affordable Care
Speaking on the occasion, Dr. Ashish Gulia, Director of HBCH&RC Punjab, stated, "The empanelment with ESIC Haryana marks another important milestone in our mission to make quality cancer care accessible and affordable for all sections of society. We remain committed to delivering patient-centric care and ensuring that no patient is deprived of treatment due to economic limitations."
This partnership underscores the ongoing efforts to expand healthcare access and reduce the financial burden on patients seeking cancer treatment in the region.
